RYR2 and Alzheimer disease: Conversely, treatment with AβOs for 1–6 h causes a decrease in RyR2 protein levels in primary hippocampal neurons (Paula-Lima et al., 2014), as does AD in its initial stages (Kelliher et al., 1999).